• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Rhinitis medicamentosa.

作者信息

Toohill R J, Lehman R H, Grossman T W, Belson T P

出版信息

Laryngoscope. 1981 Oct;91(10):1614-21. doi: 10.1288/00005537-198110000-00005.

DOI:10.1288/00005537-198110000-00005
PMID:6169966
Abstract

The diagnosis of rhinitis medicamentosa was made in 130 patients seen over a 10 year period from July 1967 to June 1977. There was an incidence of 1% in our otolaryngological practice. Patients had been taking the causal medication for an average of 21.4 months. There were 73 males and 57 females with the peak incidence in young and middle-age adults. The primary offending medications were decongestant nasal sprays in 85 patients, decongestant drops in 33, and a combination of these drugs in 12 patients. The major reasons for self-medication were 1. deviated nasal septum in 40 patients, 2. an acute upper respiratory infection in 33, 3. allergy in 18, 4. miscellaneous causes in 24 and 5. unknown in 15 patients. The initial management in addition to avoidance of the medication consisted of systemic antibiotics, decongestants, antihistamines, and sedatives depending on the severity of the rhinitis and the presence of secondary infection. Later treatment consisted of correction of the deviated septums, allergic management, and supportive care. Eight patients were considered to have complications of the disease by development of chronic ethmoiditis and nasal polyposis. The pharmacologic properties of the causal agents are thoroughly reviewed as they relate to the pathogenesis of this disease. It is felt that the ready commercial availability and limited clinical value of the topical nasal sprays and drops represents a certain risk to all patients using them.

摘要

相似文献

1
Rhinitis medicamentosa.
Laryngoscope. 1981 Oct;91(10):1614-21. doi: 10.1288/00005537-198110000-00005.
2
[Rhinitis medicamentosa in cytological assessment of the nasal mucosa].[药物性鼻炎在鼻黏膜细胞学评估中的情况]
Pol Merkur Lekarski. 2005 Sep;19(111):288-90.
3
[Clinical review of 33 cases of rhinitis medicamentosa by decongestant nasal spray].[33例使用减充血剂鼻喷雾剂所致药物性鼻炎的临床回顾]
Arerugi. 2013 Dec;62(12):1623-30.
4
Rhinitis medicamentosa: what an otolaryngologist needs to know.药物性鼻炎:耳鼻喉科医生需要了解的内容。
Eur Arch Otorhinolaryngol. 2009 May;266(5):623-5. doi: 10.1007/s00405-008-0896-1. Epub 2008 Dec 19.
5
[Pathologic conditions associated with drug-induced rhinitis].[与药物性鼻炎相关的病理状况]
Srp Arh Celok Lek. 2004 Jan-Feb;132(1-2):14-7. doi: 10.2298/sarh0402014m.
6
Rhinitis medicamentosa: a nationwide survey of Canadian otolaryngologists.药物性鼻炎:加拿大耳鼻喉科医生的全国性调查。
J Otolaryngol Head Neck Surg. 2019 Dec 9;48(1):70. doi: 10.1186/s40463-019-0392-1.
7
[The rebound of nasal resistance after decongestant used in nose].[使用减充血剂后鼻腔阻力的反弹]
Lin Chuang Er Bi Yan Hou Ke Za Zhi. 1999 Dec;13(12):560-1.
8
Rebound congestion and rhinitis medicamentosa: nasal decongestants in clinical practice. Critical review of the literature by a medical panel.反弹性充血和药物性鼻炎:临床实践中的鼻腔减充血剂。医学专家组对文献的批判性回顾。
Eur Ann Otorhinolaryngol Head Neck Dis. 2013 Jun;130(3):137-44. doi: 10.1016/j.anorl.2012.09.005. Epub 2013 Feb 1.
9
Rhinitis medicamentosa: a review of causes and treatment.药物性鼻炎:病因与治疗综述
Treat Respir Med. 2005;4(1):21-9. doi: 10.2165/00151829-200504010-00003.
10
Severe Rhinitis Medicamentosa Successfully Treated with Rhinolight® Endonasal UV Phototherapy.鼻内紫外线光疗(Rhinolight®)成功治疗重度药物性鼻炎。
Ir Med J. 2019 Feb 14;112(2):874.

引用本文的文献

1
Physiology and pathophysiology of respiratory mucosa of the nose and the paranasal sinuses.鼻和鼻窦呼吸黏膜的生理学与病理生理学
GMS Curr Top Otorhinolaryngol Head Neck Surg. 2010;9:Doc07. doi: 10.3205/cto000071. Epub 2011 Apr 27.
2
Rhinitis medicamentosa: what an otolaryngologist needs to know.药物性鼻炎:耳鼻喉科医生需要了解的内容。
Eur Arch Otorhinolaryngol. 2009 May;266(5):623-5. doi: 10.1007/s00405-008-0896-1. Epub 2008 Dec 19.
3
Vasomotor rhinitis.血管运动性鼻炎
Br Med J (Clin Res Ed). 1987 Jun 13;294(6586):1505-6. doi: 10.1136/bmj.294.6586.1505.
4
Ischaemic chest pain after abuse of a topical nasal vasodilator.滥用局部鼻血管扩张剂后出现的缺血性胸痛。
BMJ. 1989 Sep 30;299(6703):860. doi: 10.1136/bmj.299.6703.860-a.
5
Use of nasal preparations and the incidence of sinonasal cancer.鼻腔制剂的使用与鼻窦癌的发病率
J Epidemiol Community Health. 1988 Sep;42(3):243-8. doi: 10.1136/jech.42.3.243.
6
Beware congesting nasal decongestants.谨防鼻腔减充血剂造成充血。
Br Med J (Clin Res Ed). 1986 Nov 15;293(6557):1258-9. doi: 10.1136/bmj.293.6557.1258.